Combining 16S rRNA Gene Sequencing and Metabolomics to Study the Therapeutic Effects of Sangge Jiangzhi Pill on Hyperlipidemia Rats
Biomedical Chromatography · 2025
DOI: 10.1002/bmc.6089 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Xuan Pan und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning Province, China. Hauptthemen laut MEDLINE: Hyperlipidemias, Drugs, Chinese Herbal, Metabolomics, Gastrointestinal Microbiome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Applied Basic Research Program of the Department of Science and Technology of Liaoning Province, Basic Scientific Research Project of the Department of Education of Liaoning Province.
Abstract (Originalsprache)
Sangge Jiangzhi pill, as a traditional Chinese medicine compound preparation, can be used to treat hyperlipidemia. However, the specific material basis and mechanism of action of the Sangge Jiangzhi pill are not clear. In this study, gut microbiota and host metabolism were investigated using 16S rRNA sequencing and metabolomics techniques. The changes in body weight, organ index, serum biochemical levels, and liver pathology demonstrated that the Sangge Jiangzhi pill reduced body weight and attenuated fat accumulation in hyperlipidemic rats. The results of gut microbiota analysis demonstrated that the Sangge Jiangzhi pill significantly enhanced the richness and diversity of gut microbiota in hyperlipidemia rats. Moreover, it regulated the relative abundance of Ligilactobacillus , Limosilactobacillus , Lactobacillus , Blautia , Parabacteroides , Helicobacter , Colidextribacter , Desulfovibrio , Rikenella , and Tuzzerella to protect the intestinal barrier and relieve the oxidative stress reaction. Metabonomics analysis showed that a total of 32 differential metabolites were identified in feces. The results of the correlation analysis revealed a significant association between intestinal microbiota and fecal metabolites. These results suggested that the Sangge Jiangzhi pill could achieve the purpose of treating hyperlipidemia by regulating gut microbiota imbalance and metabolic activity disorder.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning Province, China.
- School of Life Sciences and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang, Liaoning Province, China.
ORCID-Profile: Miao Wang, Chunjie Zhao, Min Zhao
Förderung
- Applied Basic Research Program of the Department of Science and Technology of Liaoning Province
- Basic Scientific Research Project of the Department of Education of Liaoning Province
Zitieren
APA
Pan, X., Wang, J., Liu, S., Yu, R., Li, Z., Zhang, Y., Wang, M., Zhao, C., & Zhao, M. (2025). Combining 16S rRNA Gene Sequencing and Metabolomics to Study the Therapeutic Effects of Sangge Jiangzhi Pill on Hyperlipidemia Rats. Biomedical Chromatography. https://doi.org/10.1002/bmc.6089
Vancouver
Pan X, Wang J, Liu S, Yu R, Li Z, Zhang Y, et al. Combining 16S rRNA Gene Sequencing and Metabolomics to Study the Therapeutic Effects of Sangge Jiangzhi Pill on Hyperlipidemia Rats. Biomedical Chromatography. 2025. doi:10.1002/bmc.6089
BibTeX
@article{Pan2025,
author = {Pan, Xuan and Wang, Jianhai and Liu, Shuo and Yu, Ruonan and Li, Ziyu and Zhang, Yumeng and Wang, Miao and Zhao, Chunjie and Zhao, Min},
title = {Combining 16S rRNA Gene Sequencing and Metabolomics to Study the Therapeutic Effects of Sangge Jiangzhi Pill on Hyperlipidemia Rats},
journal = {Biomedical Chromatography},
year = {2025},
doi = {10.1002/bmc.6089}
}
EUVIMED